Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-001117

Director bought 6,000 shares at an average $4.35 ($26,120)

From the SEC's structured data for this filing

Trades in this filing

Cohen Neil Harris · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-14 Purchase : show line 1 in the form +2,000 $4.20 $8,400 6,409 D
2022-03-14 Purchase : show line 2 in the form +2,000 $4.30 $8,600 8,409 D
2022-03-14 Purchase : show line 3 in the form +2,000 $4.56 $9,120 10,409 D
Open-market purchases · 6,000 sh · avg $4.35 · $26,120

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-03-07 Grant or award : show line 4 in the form Option to Purchase American Depositary Shares +6,820 6,820 D
2021-04-19 Grant or award : show line 5 in the form Option to Purchase American Depositary Shares +11,884 11,884 D
2021-03-16 Grant or award : show line 6 in the form Option to Purchase American Depositary Shares +688 688 D
Loading xslF345X03/zk2227487.xml…